Self-reported adverse events over 6 months occurred more frequently in the cytisine group ( 288 events among 204 participants ) than in the group receiving nicotine-replacement therapy ( 174 events among 134 participants ) ; adverse events were primarily nausea and vomiting and sleep disorders .